Development of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients-March 2022-April 2023.

Development of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients-March 2022-April 2023.

Publication date: Oct 04, 2024

The epidemiology of COVID-19 has substantially changed since its emergence given the availability of effective vaccines, circulation of different viral variants, and re-infections. We aimed to develop models to predict 30-day COVID-19 hospitalization and death in the Omicron era for contemporary clinical and research applications. We used comprehensive electronic health records from a national cohort of patients in the Veterans Health Administration (VHA) who tested positive for SARS-CoV-2 between March 1, 2022, and March 31, 2023. Full models incorporated 84 predictors, including demographics, comorbidities, and receipt of COVID-19 vaccinations and anti-SARS-CoV-2 treatments. Parsimonious models included 19 predictors. We created models for 30-day hospitalization or death, 30-day hospitalization, and 30-day all-cause mortality. We used the Super Learner ensemble machine learning algorithm to fit prediction models. Model performance was assessed with the area under the receiver operating characteristic curve (AUC), Brier scores, and calibration intercepts and slopes in a 20% holdout dataset. Models were trained and tested on 198,174 patients, of whom 8% were hospitalized or died within 30 days of testing positive. AUCs for the full models ranged from 0. 80 (hospitalization) to 0. 91 (death). Brier scores were close to 0, with the lowest error in the mortality model (Brier score: 0. 01). All three models were well calibrated with calibration intercepts

Open Access PDF

Concepts Keywords
April Adult
Hospitalization Aged
Veterans Aged, 80 and over
Viral Cohort Studies
COVID-19
COVID-19 Vaccines
COVID-19 Vaccines
Female
Hospitalization
Humans
Machine Learning
Male
Middle Aged
ROC Curve
SARS-CoV-2
United States
Veterans Health

Semantics

Type Source Name
disease MESH COVID-19
disease MESH death
disease MESH re-infections
disease IDO algorithm
disease MESH Long Covid
disease MESH Infectious Diseases
disease MESH infections
drug DRUGBANK Saquinavir

Original Article

(Visited 2 times, 1 visits today)